the fmr1 disorders (fragile x syndrome, etc). mary beth busby founding board member of the fragile x...

51
The FMR1 disorders (Fragile X syndrome, etc)

Upload: mariam-shipton

Post on 16-Dec-2015

215 views

Category:

Documents


2 download

TRANSCRIPT

The FMR1 disorders(Fragile X syndrome, etc)

The FMR1 disorders(Fragile X syndrome, etc)

• Mary Beth Busbyfounding board member of the Fragile X Research Foundation (FRAXA)

• Walter KaufmannDirector, Center for Genetic Disorders of Cognition and Behavior, Kennedy Krieger Institute, The Johns Hopkins University

• Karen UsdinChief, Gene Structure and Disease SectionLMCB, NIDDK

Understanding the molecular Understanding the molecular basis of the FMR1 gene basis of the FMR1 gene

disordersdisorders

Karen UsdinKaren Usdin

5’ UTR5’ UTR

exon 1exon 1 intron 1intron 1

(CGG)n(CGG)n

promotepromoterr

X chromosome

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

FXPOI FXPOI

male

female

The Repeat Expansion Diseases

Myotonic Myotonic dystrophdystroph

yytype 1type 1

Myotonic Myotonic dystrophdystroph

yytype 1type 1

Also: SCA 8, SCA12, and HDL2Also: SCA 8, SCA12, and HDL2Also: SCA 8, SCA12, and HDL2Also: SCA 8, SCA12, and HDL2

FMR1 FMR1 disordersdisorders

FMR1 FMR1 disordersdisorders

Friedreich Friedreich ataxiaataxia

Friedreich Friedreich ataxiaataxia

Haw River SyndromeHaw River Syndrome(DRPLA)(DRPLA)

Haw River SyndromeHaw River Syndrome(DRPLA)(DRPLA)

HuntingtoHuntington diseasen diseaseHuntingtoHuntington diseasen disease

SCA 1, 2, 6, 7SCA 1, 2, 6, 7SCA 1, 2, 6, 7SCA 1, 2, 6, 7

Kennedy DiseaseKennedy Disease(SBMA)(SBMA)

Kennedy DiseaseKennedy Disease(SBMA)(SBMA)

Progressive Progressive myoclonus myoclonus epilepsyepilepsy

Progressive Progressive myoclonus myoclonus epilepsyepilepsy

FRAXE MRFRAXE MRFRAXE MRFRAXE MR

SCA10SCA10SCA10SCA10 Myotonic Myotonic dystrophydystrophy

type 2type 2

Myotonic Myotonic dystrophydystrophy

type 2type 2

ORPromoter 5’ UTR ORF 3’ UTRIntron

(CGG)n (CTG)n(CAG)n(GAA)n (ATTCT)n(C4GC4GCG)n (CCTG)n

gametogenesis

Premutation symptoms result from RNA “toxicity”

Premutation symptoms result from RNA “toxicity”

• The RNA is somehow deleterious

• the CGG-repeats may• trigger deleterious processes • sequester proteins that are

important for normal neuronal and ovarian function

QuickTime™ and a decompressor

are needed to see this picture.

QuickTime™ and a decompressor

are needed to see this picture.

RNA “toxicity” hypothesisRNA “toxicity” hypothesis

• The RNA is somehow deleterious

• the CGG-repeats may initiate or trigger deleterious processes

• the CGG-repeats may sequester proteins that are important for normal neuronal and ovarian function

RNA interferenceRNA interference

Hannon (2002)

SK cells

DAPI

lamin

merge

SK cells+CGG88

Is FXTAS a laminopathy?Is FXTAS a laminopathy?

• mutations in Lamin A/C are associated with one form of Charcot-Marie-Tooth disease, a neurological disorder

• other mutations in Lamin A/C result in premature aging

Gene silencingin mammals

DNA methylation

Histone modifications

Science, 1991

5-azadeoxycytidine

What does FMRP do?What does FMRP do?

•learning difficulties•macroorchidism•altered circadian rhythms•rapid early growth rate•audiogenic seizures•anxiety

QuickTime™ and aVC Coding

QuickTime™ and aVC Coding

QuickTime™ and aVC Coding

QuickTime™ and aVC Coding

Qin and Beebe-Smith (NIMH)

WT

KO

FMRP structureFMRP structure

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

NDF

RNAs bound by FMRPRNAs bound by FMRP

• FMR1• Glucocorticoid receptor• GABAA receptor subunits• CAMKIIα• MAP1B• Rac1• Calbindin• Vimentin• etc, etc

protein product

Protein gel

- FMRP

FMRPI3

04N

Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation

Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation

Qin, Kang, and Beebe Smith (2002) (NIMH)

WT

KO

Nissl staining [14C] DG

Results of “fishing” for FMRP interacting proteins

Results of “fishing” for FMRP interacting proteins

• FXR1P• FXR2P• CYFIP1 and CYFIP2• Poly(A)-binding protein• eIF2C2/AGO1 • Dicer • kinesin heavy chain

RNA interferenceRNA interference

Hannon (2002)

QuickTime™ and aYUV420 codec decompressor

are needed to see this picture.

axon

dendritesynapse

Grazyna Gorny

QuickTime™ and aYUV420 codec decompressor

are needed to see this picture.

Synaptic transmissionSynaptic transmission

FXS Un Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome

Irwin, Galvez and William T. Greenough

Cerebral Cortex (2000)

Results of “fishing” for FMRP interacting proteins

Results of “fishing” for FMRP interacting proteins

• FXR1P• FXR2P• CYFIP1 and CYFIP2• Poly(A)-binding protein• eIF2C2/AGO1 • Dicer • kinesin heavy chain

FMRP

RISC

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

mGluR5 receptor

WTFX

MG+/-

FX/MG+/-

MinocyclineMinocycline

Metalloproteinase-9 (MMP-9)Metalloproteinase-9 (MMP-9)

Take home messagesTake home messages

• FXTAS and FXPOI result from repeat-induced hyperexpression of the FMR1 gene and the deleterious effects of high levels of CGG-repeat containing mRNA.

• FXS results from repeat-induced gene silencing.• silencing leads to a deficiency of FMRP, a protein

important for the regulation of translation in the synapses of neurons

• the resultant abnormal expression of proteins like mGluR5, GSK-3, GABAA and MMP-9 results in the symptoms of FXS

• normalizing expression of these proteins may provide targeted approaches to the treatment of FXS.